The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases.

Filiacions

Zilli T:

Department of Radiation oncology, Geneva University Hospital, Geneva, Switzerland

Dirix P:

Department of Radiation Oncology, Iridium Kankernetwerk, Antwerp, Belgium

University of Antwerp, Faculty of Medicine and Health Sciences, Antwerp, Belgium

Heikkilä R:

Department of Oncology, Oslo University Hospital, Oslo, Norway

Liefhooghe N:

Department of Radiation oncology, AZ Groeninge, Kortrijk, Belgium

Siva S:

Epworth Healthcare and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia

Gomez-Iturriaga A:

Biocruces Health Research Institute, Cruces University Hospital, Barakaldo, Spain

Everaerts W:

Department of Development and Regeneration, KU Leuven, Leuven, Belgium

Otte F:

Department of Radiation oncology, Jules Bordet Institute and Hôpital Erasme, University Clinics of Brussels, Université Libre de Bruxelles, Brussels, Belgium

Shelan M:

Department of Radiation oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland

Mercier C:

Department of Radiation Oncology, Iridium Kankernetwerk, Antwerp, Belgium

University of Antwerp, Faculty of Medicine and Health Sciences, Antwerp, Belgium

Achard V:

Department of Radiation oncology, Geneva University Hospital, Geneva, Switzerland

Thon K:

Department of Oncology, Oslo University Hospital, Oslo, Norway

Stellamans K:

Department of Radiation oncology, AZ Groeninge, Kortrijk, Belgium

Moon D:

Royal Melbourne Clinical School, University of Melbourne, Melbourne, Australia

Conde-Moreno A:

Department of Radiation oncology, Hospital Universitari i Politècnic la Fe, Valencia, Spain

Papachristofilou A:

Department of Radiotherapy and Radiation Oncology, University Hospital Basel, Basel, Switzerland

Scorsetti M:

Radiotherapy and Radiosurgery Department, Humanitas Clinical and Research Hospital IRCSS, Rozzano, Italy

Gückenberger M:

Department of Radiation Oncology, University Hospital Zürich, University of Zurich, Zürich, Switzerland

Ameye F:

Department of Urology, AZ Maria-Middelares, Ghent, Belgium

Zapatero A:

Department of Radiation Oncology, University Hospital La Princesa, Madrid, Spain

Van De Voorde L:

Department of Radiation Oncology, AZ St-Lucas, Ghent, Belgium

López Campos F:

Department of Radiation Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain

Couñago F:

Department of Radiation Oncology, University Hospital Quironsalud, Universidad Europea de Madrid, Madrid, Spain

Jaccard M:

Department of Radiation oncology, Geneva University Hospital, Geneva, Switzerland

Spiessens A:

Department of Radiation oncology and experimental cancer research, Ghent University Hospital, Ghent, Belgium

Semac I:

Department of Radiation oncology, Geneva University Hospital, Geneva, Switzerland

Vanhoutte F:

Department of Radiation oncology and experimental cancer research, Ghent University Hospital, Ghent, Belgium

Goetghebeur E:

Department of Applied Mathematics, Computer Science and Statistics, Ghent University, Ghent, Belgium

Reynders D:

Department of Applied Mathematics, Computer Science and Statistics, Ghent University, Ghent, Belgium

Ost P:

Department of Radiation oncology and experimental cancer research, Ghent University Hospital, Ghent, Belgium